NYSE · Healthcare · Diagnostics & Research · USA
Mettler-Toledo International Inc is a large cap company (market value between $10 billion and $200 billion) in the Diagnostics & Research industry.
Mettler-Toledo International supplies weighing instruments, analytical equipment, and inspection systems used in pharmaceutical, food, chemical, and academic settings. The company operates globally across multiple geographic regions, serving customers through laboratory solutions, industrial instruments, product quality assurance devices, and retail weighing technology.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Mettler-Toledo International Inc stock.
Overvalued: intrinsic value $637.04 per share, market price $1634.01, margin of safety -156.5% (as of 2026-10-20).
Discounting its cash flows at 10.3% (average of 3 methods) values the shares at $637.04; the price of $1,634.01 is 156% above that value, and 71% of that value comes from beyond year five.
Leak Score: 64/100 on 10 of 12 signals (Faint Leak).
17 more funds hold it; the full list is part of the paid plan.
All 44 Diagnostics & Research stocks
9 more in this industry show a wider margin of safety.
MTD is overvalued (as of the 2026-10-20 close). Discounting its cash flows at 10.3% (average of 3 methods) values the shares at $637.04; the price of $1,634.01 is 156% above that value, and 71% of that value comes from beyond year five.
$637.04 per share (as of the 2026-10-20 close), against a market price of $1634.01. That is a margin of safety of -156.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
64 out of 100, which we rate "Faint Leak", on 10 of 12 value investing signals.